openPR Logo
Press release

Global Diabetes Devices Market 2017-2025| Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S And F. Hoffmann-La Roche Ltd

08-13-2018 06:29 AM CET | Health & Medicine

Press release from: Diabetes Devices Market

Global Diabetes Devices Market 2017-2025| Medtronic plc,

Albany, NY, 13th August : Recent research and the current scenario as well as future market potential of "Diabetes Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" globally.

This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1461372

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global optometry market.

Diabetes Devices Market: Segmentation

Diabetes Mellitus is a chronic condition in which our body is unable to produce or utilize insulin for converting blood glucose into energy. Globally around 415 million people are living with diabetes. Half of the world’s population suffering with diabetes still remains undiagnosed. It is studied that 90% of diabetes cases are of type 2 diabetes. The diabetes devices market has a huge scope during the forecast period. The global diabetes devices market can be segmented based on product type, distribution channel and region.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/diabetes-devices-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html/toc

Depending on the product type the global diabetes devices market includes Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Monitoring Software and Artificial Pancreas System. The Glucose Monitoring Devices includes four main sub-segments viz. self -monitoring blood glucose meters, blood glucose testing strips, lancets and continuous glucose monitoring meters. Insulin delivery devices segment includes insulin syringes, insulin pens and insulin pumps. The Glucose Monitoring Devices segment is projected to be a highly attractive segment of the global diabetes devices market during the forecast period. The segment is anticipated to be expand at a CAGR of 6.7% during the forecast period. Self- monitoring blood glucose meters segment contributes maximum share to the global diabetes devices market in terms of revenue. High prevalence of diabetes due to factors such as lifestyle changes, high life expectancy and increased urbanization drives this segment of the Diabetes Devices market as people have become more careful about their health conditions and thus regularly monitor their blood glucose levels.

Based on the distribution channel, the global diabetes devices market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and diabetes clinics/centers. The hospital pharmacy segment contributes maximum share in terms of revenue in the forecast period.

Diabetes Devices Market: Geographical and Competitive Dynamics

Geographically, the global diabetes devices market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the diabetes devices market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd.

Global diabetes devices market is segmented as follows:

Global Diabetes Devices Market Revenue, by Product Type

Glucose Monitoring Devices
Self- monitoring blood glucose meters
Blood glucose testing strips
Lancets
Continuous glucose monitoring meters
Insulin Delivery Devices
Insulin syringes
Insulin pens
Insulin pumps
Diabetes Management Software
Artificial Pancreas System

Global Diabetes Devices Market Revenue, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Diabetes Clinics/ Centres

Global Diabetes Devices Market Revenue, by Region

North America
US
Canada
Europe
Germany
France
Italy
Spain
UK
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries
South Africa
Rest of Middle East & Africa

Browse Report @ https://www.researchmoz.us/diabetes-devices-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html

Latin America
Brazil
Mexico
Rest of Latin America

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket Ghumare,
ResearchMoz,
90 State Street, Albany NY, United States,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Follow me on : https://marketinfo247.wordpress.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Diabetes Devices Market 2017-2025| Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S And F. Hoffmann-La Roche Ltd here

News-ID: 1175042 • Views:

More Releases from Diabetes Devices Market

Global Diabetes Devices Market Insights and Trends to 2025: Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd.
Global Diabetes Devices Market Insights and Trends to 2025: Medtronic plc, Sanof …
ResearchMoz include new market research report "Diabetes Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of
Business Strategy of Diabetes Devices Market in Global Industry 2018
Business Strategy of Diabetes Devices Market in Global Industry 2018
Albany, NY, 11th April : Recent research and the current scenario as well as future market potential of "Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)" globally. Diabetes, referred to as diabetes mellitus by doctors, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1329707 Diabetes can either be due to pancreas not producing enough insulin
Regulatory Requirements of Diabetes Devices Market in Global Industry : Overview, Size, Share, Trends, Analysis and Research 2017-2025
Regulatory Requirements of Diabetes Devices Market in Global Industry : Overview …
Researchmoz added Most up-to-date research on "Diabetes Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. Global Diabetes Devices Market: Scope and Methodology This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and

All 4 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact